Sofamor ends lagreement with ANS (Advanced Neuromodulation Systems):
This article was originally published in Clinica
Sofamor Danek and Advanced Neuromodulation Systems (ANS) have ended their agreement under which ANS was to develop and manufacture products and systems for Sofamor for use in deep brain stimulation. The agreement, which dates back to June, is being terminated owing to the acquisition of Sofamor by Medtronic. Sofamor will accelerate the $8 million payments due to ANS, which will release Sofamor from its commitments. Dallas-based ANS says it will continue to look for other partners for its electrical stimulation technology, which is used to relieve the effects of neurological disorders, such as Parkinson's disease.